Home

Vista Pharmaceuticals Ltd EPS

Image

Vista Pharmaceuticals Ltd

NSE: VISTAPHARMA

EPS

₹ -0.79

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Vista Pharmaceuticals Ltd is ₹ -0.79 as of 21 Feb 25 .
  • The earning per share of Vista Pharmaceuticals Ltd changed from ₹ -0.23 to ₹ -0.07 over 7 quarters. This represents a CAGR of -49.33% .

Historical Earning per Share of Vista Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Vista Pharmaceuticals Ltd

Market Cap

43 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

1.0

Day’s High

11.25

Day’s Low

10.51

DTE

0.1

ROE

-7.0

52 Week High

16.59

52 Week Low

9.1

ROCE

-6.6

Market Price of Vista Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Vista Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202511.25
20 Feb 202510.98
19 Feb 202510.6
18 Feb 202510.7
17 Feb 202510.82
14 Feb 202511.15
13 Feb 202510.9
12 Feb 202510.7
11 Feb 202510.78
10 Feb 202510.84

SWOT Analysis Of Vista Pharmaceuticals Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Vista Pharmaceuticals Ltd

Asset Value vs Market Value of Vista Pharmaceuticals Ltd

Market Value

44

Asset Value

Value addition

0.6 X

27

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Vista Pharmaceuticals Ltd43.67
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Vista Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Vista Pharmaceuticals Ltd News Hub

Vista Pharmaceuticals reports standalone net loss of Rs 0.86 crore in the June 2024 quarter

Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as agains

Read more

14 Aug 24

Vista Pharmaceuticals to discuss results

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

06 Aug 24

Vista Pharmaceuticals to conduct AGM

Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company will be he

Read more

10 Sept 24

Vista Pharmaceuticals reports standalone net loss of Rs 0.97 crore in the September 2024 quarter

Net Loss of Vista Pharmaceuticals reported to Rs 0.97 crore in the quarter ended September 2024 as a

Read more

14 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Vista Pharmaceuticals Ltd

What is the EPS of Vista Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Vista Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Vista Pharmaceuticals Ltd EPS calculated?

The EPS of Vista Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Vista Pharmaceuticals Ltd report its EPS?

Vista Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Vista Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Vista Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Vista Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Vista Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions